These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26961184)

  • 41. Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs.
    Alnaqbi KA; Elezbawy B; Fasseeh AN; Bangash AR; Elshamy A; Shendi H; Aftab MI; AlMarshoodi M; Gebran N; AlDhaheri N; Fahmy SA; Al Dallal S; Al Naeem W; Abaza S; Kaló Z
    Cureus; 2024 Feb; 16(2):e55215. PubMed ID: 38558740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England.
    Khanal S; Schmidtke KA; Talat U; Turner AM; Vlaev I
    Front Health Serv; 2023; 3():1155523. PubMed ID: 37409178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identifying and measuring stakeholder preferences for disease prioritisation: A case study of the pig industry in Australia.
    Brookes VJ; Hernández-Jover M; Neslo R; Cowled B; Holyoake P; Ward MP
    Prev Vet Med; 2014 Jan; 113(1):118-31. PubMed ID: 24211106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
    Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
    Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of multi-criteria decision analysis in regulatory alternatives analysis: a case study of lead free solder.
    Malloy TF; Sinsheimer PJ; Blake A; Linkov I
    Integr Environ Assess Manag; 2013 Oct; 9(4):652-64. PubMed ID: 23703936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature.
    Marsh K; Lanitis T; Neasham D; Orfanos P; Caro J
    Pharmacoeconomics; 2014 Apr; 32(4):345-65. PubMed ID: 24504851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can multi-criteria decision analysis (MCDA) be implemented into real-world drug decision-making processes? A Canadian provincial experience.
    Laba TL; Jiwani B; Crossland R; Mitton C
    Int J Technol Assess Health Care; 2020 Aug; ():1-6. PubMed ID: 32762789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determining the value contribution of selexipag for the treatment of pulmonary arterial hypertension (PAH) in Spain using reflective multi-criteria decision analysis (MCDA).
    Jiménez A; Ais A; Beaudet A; Gil A
    Orphanet J Rare Dis; 2018 Dec; 13(1):220. PubMed ID: 30526673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design of a multiple criteria decision analysis framework for prioritizing high-impact health technologies in a regional health service.
    Sánchez-Martínez FI; Abellán-Perpiñán JM; Martínez-Pérez JE; Gómez-Torres JL
    Int J Technol Assess Health Care; 2024 Apr; 40(1):e21. PubMed ID: 38576122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Personal exposure to mixtures of volatile organic compounds: modeling and further analysis of the RIOPA data.
    Batterman S; Su FC; Li S; Mukherjee B; Jia C;
    Res Rep Health Eff Inst; 2014 Jun; (181):3-63. PubMed ID: 25145040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multicriteria decision analysis in ranking of analytical procedures for aldrin determination in water.
    Tobiszewski M; Orłowski A
    J Chromatogr A; 2015 Mar; 1387():116-22. PubMed ID: 25704773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Guidance toward the implementation of multicriteria decision analysis framework in developing countries.
    Inotai A; Nguyen HT; Hidayat B; Nurgozhin T; Kiet PHT; Campbell JD; Németh B; Maniadakis N; Brixner D; Wijaya K; Kaló Z
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):585-592. PubMed ID: 30092151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using multiple criteria decision analysis for supporting decisions of solid waste management.
    Cheng S; Chan CW; Huang GH
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2002; 37(6):975-90. PubMed ID: 12090287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analysis (MCDA).
    Rutten-van Mölken M; Leijten F; Hoedemakers M; Tsiachristas A; Verbeek N; Karimi M; Bal R; de Bont A; Islam K; Askildsen JE; Czypionka T; Kraus M; Huic M; Pitter JG; Vogt V; Stokes J; Baltaxe E;
    BMC Health Serv Res; 2018 Jul; 18(1):576. PubMed ID: 30041653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vulnerability assessment of atmospheric environment driven by human impacts.
    Zhang Y; Shen J; Ding F; Li Y; He L
    Sci Total Environ; 2016 Nov; 571():778-90. PubMed ID: 27424115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Facilitating the Decision-Making Process After a Nuclear Accident: Case Studies in the Netherlands and Slovakia.
    van Asselt ED; Twenhöfel CJ; Duranova T; Smetsers RC; Bohunova J; Müller T
    Integr Environ Assess Manag; 2021 Mar; 17(2):376-387. PubMed ID: 33225604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Knowledge Translation in Practice: Exploring the Potential Use of MCDA in Central America and the Caribbean.
    Espinoza MA; Rojas R; Acosta de Patiño H
    Value Health Reg Issues; 2018 Dec; 17():148-149. PubMed ID: 30184512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does technique matter; a pilot study exploring weighting techniques for a multi-criteria decision support framework.
    van Til J; Groothuis-Oudshoorn C; Lieferink M; Dolan J; Goetghebeur M
    Cost Eff Resour Alloc; 2014; 12():22. PubMed ID: 25904823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estimating the value of medical treatments to patients using probabilistic multi criteria decision analysis.
    Broekhuizen H; Groothuis-Oudshoorn CG; Hauber AB; Jansen JP; IJzerman MJ
    BMC Med Inform Decis Mak; 2015 Dec; 15():102. PubMed ID: 26626279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.